Despite MDT, a limited drug screen revealed enhanced sensitivity of PCa cells in the Enz-tolerant state to U18666A (Fig. S2H), an inhibitor of the lysosomal Niemann-Pick C1 protein (NPC1). Here, NPC1 is linked to posterior cortical atrophy.